What is the appropriate starting dose of levetiracetam for a 36 kg child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Levetiracetam Starting Dose for 36 kg Child

For a 36 kg child with partial onset seizures, start levetiracetam at 720 mg/day (360 mg twice daily), which equals 20 mg/kg/day in two divided doses. 1

Dosing Algorithm

The FDA-approved dosing for pediatric patients ages 4 to <16 years follows this structured approach 1:

Initial Dosing

  • Starting dose: 20 mg/kg/day divided into two doses (10 mg/kg BID)
  • For a 36 kg child: 720 mg/day total (360 mg twice daily)

Titration Schedule

  • Increase every 2 weeks by increments of 20 mg/kg/day
  • Target dose: 60 mg/kg/day (30 mg/kg BID)
  • For a 36 kg child, this means:
    • Week 0-2: 720 mg/day (360 mg BID)
    • Week 2-4: 1440 mg/day (720 mg BID)
    • Week 4+: 2160 mg/day (1080 mg BID) - target dose

Formulation Selection

For a 36 kg child, either tablets or oral solution can be used 1. The FDA label specifies that patients ≤20 kg should use oral solution, while those >20 kg can use either formulation.

Using the tablet dosing guide for 36 kg 1:

  • Initial (20 mg/kg/day): 500 mg BID (1 × 500 mg tablet twice daily)
  • Intermediate (40 mg/kg/day): 1000 mg BID (1 × 500 mg tablet twice daily, doubled)
  • Target (60 mg/kg/day): 1500 mg BID (1 × 750 mg tablet twice daily)

Important Clinical Considerations

Tolerability

If the child cannot tolerate 60 mg/kg/day, the dose may be reduced 1. Clinical trial data showed a mean daily dose of 52 mg/kg in the pediatric efficacy study, indicating some patients required lower maintenance doses.

Efficacy Evidence

The 60 mg/kg/day target is evidence-based: a pediatric trial demonstrated that this dose significantly reduced partial seizure frequency by 26.8% over placebo, with a responder rate (≥50% seizure reduction) that was statistically significant 1. Lower doses have not been adequately studied for efficacy 1.

Common Pitfalls to Avoid

  • Don't underdose: Starting at 20 mg/kg/day is critical - lower doses lack efficacy data
  • Don't rush titration: The 2-week intervals allow assessment of tolerability
  • Don't use household measuring devices: For oral solution, use calibrated measuring devices 1
  • Weight-based dosing is essential: Pediatric clearance is approximately 40% higher than adults, requiring higher mg/kg doses 1

Administration

Levetiracetam can be given with or without food 1. The twice-daily dosing schedule maintains therapeutic levels given the 5-7 hour half-life in children 1.

References

Related Questions

What is the appropriate levetiracetam (Lev pil) dose for a 12‑year‑old girl?
What is the recommended levetiracetam (Levepil) dose for a 10‑year‑old child?
Does levetiracetam (Levo) cause fatigue?
In an 80‑kg man presenting with convulsions, how should intravenous levetiracetam be dosed (loading dose, infusion rate, maintenance schedule, renal adjustment, and transition to oral therapy)?
What laboratory tests should be ordered for a patient on levetiracetam (Keppra)?
Can obsessive‑compulsive disorder coexist with mood disorders and with depersonalization/derealization disorder?
In a patient with ankylosing spondylitis receiving infliximab (Remicade), peripheral blood shows a markedly expanded CD4‑dominant clonal T‑cell population (36 % of lymphocytes, CD4/CD8 ratio 13.5) with an aberrant immunophenotype (CD3 weak+, CD4+, CD8‑, CD2 weak+, CD5 weak+, CD7‑, CD26‑, CD57+, CD16‑, CD56‑) and a monotypic T‑cell receptor β1 pattern, but no skin lesions; with a pending PET‑CT, what is the appropriate next diagnostic and therapeutic approach?
What are the indications, benefits, and potential adverse effects of evening primrose oil supplementation?
What are the functions of vitamin D3 (cholecalciferol) and what is the recommended dosage for adults?
What is the recommended dosing and schedule of bevacizumab for newly diagnosed stage III–IV epithelial ovarian, fallopian tube, or primary peritoneal cancer and for recurrent disease?
Given a basic metabolic panel with normal glucose, blood urea nitrogen, electrolytes, and calcium but a mildly elevated creatinine and an estimated glomerular filtration rate of 64 mL/min/1.73 m² (stage 2 chronic kidney disease), what steps should I take to manage this?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.